zhaoran su

Dr. zhaoran su


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2016 in FEBS Letters
Verified
Journal Article
Open access
PDF file
ZSzhaoran su
zhaoran su
XZXiaofei Zhi
Xiaofei Zhi
QZQun Zhang
Qun Zhang
LYLi Yang
Li Yang
HXHao Xu
Hao Xu
ZXZekuan Xu
Zekuan Xu
Intestinal barrier dysfunction is a significant clinical problem, which develops in a variety of acute or chronic pathological conditions. In a previous study, we found that microRNA‐874 (miR‐874) suppresses aquaporin‐3 (AQP3) expression, which contributes significantly to intestinal barrier dysfunction. Recently, a new regulatory circuit was identified in which RNA can crosstalk with each other by competing for shared miRNA. Here, we show that the human long noncoding RNA (lncRNA) H19 may function as a competing endogenous RNA (ceRNA) to regulate the expression of AQP3 through competition for miR‐874, thus playing a significant role in maintaining intestinal barrier function.

12 October 2022 in Cancer Biomarkers
Verified
Journal Article
Closed access
PDF file
ZSzhaoran su
zhaoran su
KSKuanshan Shu
Kuanshan Shu
GLGuangyao Li
Guangyao Li
BACKGROUND: The prognostic role of annexin A5 (ANXA5) in stomach adenocarcinoma (STAD) has not been studied, and its relationship with immune infiltration is still unclear. OBJECTIVE: This investigation aimed at exploring the role of ANXA5 in STAD using an integrated bioinformatics analysis. METHODS: The expression of ANXA5 in STAD and the correlations between the effect of ANXA5 and survival of STAD patients were investigated using database. The clusterProfiler package in R software was used to perform enrichment analysis on the top 100 co-expressed genes of ANXA5 from the COXPRESdb online database. Correlations between ANXA5 and immune cell infiltrates were analyzed using the TIMER database. RESULTS: In STAD, ANXA5 expression was significantly upregulated and increased ANXA5 expression was significantly correlated with poor overall survival (P< 0.05). In multivariate analysis, upregulated ANXA5 expression was an independent predictive factors of poor prognosis (P< 0.05). The co-expressed genes were involved in extracellular matrix (ECM)-related processes. In STAD, ANXA5 expression was significantly correlated with various infiltrating immune cells (P< 0.05). CONCLUSIONS: Together with our findings, ANXA5 could serve as a potential biomarker to assess prognosis and immune infiltration level in STAD.

1 September 2013 in Hepatogastroenterology
Verified
Journal Article
Closed access
ZSzhaoran su
zhaoran su
KSKuanshan Shu
Kuanshan Shu
MZMing Zheng
Ming Zheng
XSXuegong Sun
Xuegong Sun
ZFZhiheng Fang
Zhiheng Fang
GWGuihe Wang
Guihe Wang
The aim of the present study was to investigate localization and distribution of sentinel lymph node (SLN) in gastric cancer and influenced factors of skip metastasis. Eighty-nine cases with solitary or single station metastatic lymph nodes (LNs) among 779 gastric cancer patients were included in this study. D2 or D2+ lymph node dissection with total or distal gastrectomy had been performed. The location of SLNs and characteristics were analyzed retrospectively. Seventy-one patients (79.8%) had SLNs at the first level of the regional LN group and 18 cases (20.2%) had skip metastases SLNs. NO.7 (44.4%) and NO.8a (27.8%) were the most common sites of skip metastases. Multivariate analysis identified the differentiated degree of tumor as the only significant influenced factor of skip metastases (p=0.031). The number of metastatic SLNS was significantly greater in advanced gastric cancer patients (2.4 ± 1.4) than early gastric cancer patients (1.5 ± 0.9) (pT4 vs. pT1, p=0.002; pT4 vs. pT2, p=0.014; pT3 vs. pT1, p=0.018). The differentiated degree of gastric cancer is the most important influenced factor of skip metastases and NO.7 and NO.8a are the most important N2 LN stations that should be observed when lymphadenectomy is performed.

16 March 2013 in Hepatogastroenterology
Verified
Journal Article
Closed access
ZSzhaoran su
zhaoran su
ZCZhong-Lu Cui
Zhong-Lu Cui
JMJin-Liang Ma
Jin-Liang Ma
JLJian-Sheng Li
Jian-Sheng Li
Yong GeYong Ge
Yong Ge
WJWei-Dong Jia Jia
Wei-Dong Jia Jia
Hepatectomy is associated with high rates of postoperative liver dysfunction in patients with cirrhosis. Since S-adenosyl-L-methionine (SAMe) can be used to treat liver disease, we performed a prospective clinical trial to investigate whether it could be used after hepatectomy to benefit residual liver function. We studied 79 hepatitis-related chronic patients who underwent resection of hepatocellular carcinoma; 39 patients were randomly assigned to receive postoperative intravenous SAMe treatment, and 40 were randomly assigned to a control group. The postoperative SAMe treatment consisted of SAMe 1,000mg given intravenously for seven days. The other treatment was standardized. At inclusion into the trial no significant differences were observed between the two groups with respect to gender, age, Child classification, preoperative liver function tests, blood loss, total time of hepatic pedicle occlusion and the extent of liver resection. The overall frequency of postoperative liver insufficiency decreased from 42% in the control group to 31% in the SAMe group, although not statistically significant (p=0.121). When the patients who underwent hepatic pedicle occlusion by Pringle’s maneuver over 15min were analyzed, the frequency of postoperative liver insufficiency (p=0.028), serum total bilirubin levels on days 5 (p=0.025) and 7 (p=0.032) preoperatively, and the maximum value of postoperative serum total bilirubin (p=0.040) were significantly greater in the control than in the SAMe group. The results indicate that the postoperative SAMe therapy can benefit residual liver function of the patients with cirrhosis, especially in those suffering greater ischemia reperfusion injury.

12 September 2022 in BioMed Research International
Verified
Journal Article
Open access
ZSzhaoran su
zhaoran su
JWJia Weidong
Jia Weidong
Aims. The purpose of this study was to investigate the correlation of INSC gene with the level of immune infiltration and clinical prognosis in colon adenocarcinoma (COAD) patients. Materials and Methods. INSC expression profile data and clinicopathological information of COAD patients were downloaded from TCGA. Xiantao bioinformatics tool was used to analyze the expression of INSC between the COAD group and the normal control group, and GEPIA2 was used to analyze the top 100 coexpressed genes. Logistic regression analysis was performed to assess the relationship between clinicopathological features and INSC. The Kaplan‐Meier method and Cox regression model were used to perform the survival analysis. CIBERSORT algorithm was used to analyze the relationship between INSC expression and immune infiltration cells. Results. The expression level of INSC in COAD was significantly downregulated. The result of logistic regression analysis confirmed that tumor stage was the final influencing factor of INSC expression. The overall survival rate of INSC in the high expression group was higher than that of the low expression group, and it was an independent risk factor of prognosis. Enrichment results indicated that INSC was enriched in the regulation of T‐helper 2 cell differentiation pathway. Immune infiltration analysis showed that INSC expression was positively correlated with the B cell plasma, T cell CD4+ memory resting, activated myeloid dendritic cells, and eosinophils. Conclusions. Our study found that the expression of INSC was significantly downregulated in COAD, which regulated immune‐infiltrating cells during cancer development and was associated with malignant progression in COAD patients.

1 June 2019 in Medicine
Verified
Journal Article
Open access
ZSzhaoran su
zhaoran su
KSKuanshan Shu
Kuanshan Shu
MKMin Kang
Min Kang
GWGuihe Wang
Guihe Wang
Rationale: Gastric cancer is still one of the most common cancer in East Asia. More than 70% gastric cancer patients are diagnosed at an advanced stage in China. Moreover, about 10% cases are unresectable which usually suffer a poor prognosis with a median survival time of 5 to 12 months. In recent years, some clinical studies found that many unresectable gastric cancer cases could get opportunity for surgery after treatment that improve prognosis significantly Patient concerns: 64-year-old male patient was admitted with upper abdominal pain. Upper gastrointestinal endoscopy showed a large ulcerated tumor located from the cardia to the anterior wall of the upper gastric body. Histopathological examination showed it was moderately differentiated adenocarcinoma. Computed tomography (CT) scan image showed a large bulging mass with internal ulcer at the lesser curvature wall, left gastric artery and coeliac trunk were surrounded by fused lymph nodes. Diagnoses: Based on the histopathological examination and imaging findings, patient was diagnosed advanced gastric cancer and hardly to resect radically. Intervention: Oral chemotherapy combined with trans-arterial chemotherapy and embolization (TACE) was initiated. Eight weeks after initial therapy, radical laparoscopy-assisted total gastrectomy with D2 lymph node dissection and Roux-en-Y anastomosis were performed successfully. Outcomes: Patient was discharged on postoperative day 11 without complications. Histological analysis of the specimen and resected 31 lymph nodes revealed no malignancy. The patient experienced a pathological complete response (pCR). Lessons: In this case, oral chemotherapy combined with TACE which was rarely reported in the treatment of unresectable gastric cancer achieves a great therapeutic benefit. Although further clinical studies will be needed to establish, it may be a potent strategy for degrading stage and supplying a new chance for surgery.